Search results for the GEO ID: GSE30516
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM756853
GPL570
Part 1: BT20 0 minute time point rep1 BT20 cells, 0 minutes post treatment with 10µM concentration of erlotinib time post treatment: 0 minutes treatment: 10 µM erlotinib cell line: BT20
GSM756854
GPL570
Part 1: BT20 0 minute time point rep2 BT20 cells, 0 minutes post treatment with 10µM concentration of erlotinib time post treatment: 0 minutes treatment: 10 µM erlotinib cell line: BT20
GSM756855
GPL570
Part 1: BT20 0 minute time point rep3 BT20 cells, 0 minutes post treatment with 10µM concentration of erlotinib time post treatment: 0 minutes treatment: 10 µM erlotinib cell line: BT20
GSM756856
GPL570
Part 1: BT20 30 minute time point rep1 BT20 cells, 30 minutes post treatment with 10µM concentration of erlotinib time post treatment: 30 minutes treatment: 10 µM erlotinib cell line: BT20
GSM756857
GPL570
Part 1: BT20 30 minute time point rep2 BT20 cells, 30 minutes post treatment with 10µM concentration of erlotinib time post treatment: 30 minutes treatment: 10 µM erlotinib cell line: BT20
GSM756858
GPL570
Part 1: BT20 30 minute time point rep3 BT20 cells, 30 minutes post treatment with 10µM concentration of erlotinib time post treatment: 30 minutes treatment: 10 µM erlotinib cell line: BT20
GSM756859
GPL570
Part 1: BT20 1 day time point rep1 BT20 cells, 24 hour post treatment with 10µM concentration of erlotinib time post treatment: 24 hours treatment: 10 µM erlotinib cell line: BT20
GSM756860
GPL570
Part 1: BT20 1 day time point rep2 BT20 cells, 24 hour post treatment with 10µM concentration of erlotinib time post treatment: 24 hours treatment: 10 µM erlotinib cell line: BT20
GSM756861
GPL570
Part 1: BT20 1 day time point rep3 BT20 cells, 24 hour post treatment with 10µM concentration of erlotinib time post treatment: 24 hours treatment: 10 µM erlotinib cell line: BT20
GSM756862
GPL570
Part 1: BT20 0 minute time point rep4 BT20 cells, 0 minutes post treatment with 10µM concentration of erlotinib time post treatment: 0 minutes treatment: 10 µM erlotinib cell line: BT20
GSM756863
GPL570
Part 1: BT20 6 hour time point rep1 BT20 cells, 6 hour post treatment with 10µM concentration of erlotinib time post treatment: 6 hours treatment: 10 µM erlotinib cell line: BT20
GSM756864
GPL570
Part 1: BT20 6 hour time point rep2 BT20 cells, 6 hour post treatment with 10µM concentration of erlotinib time post treatment: 6 hours treatment: 10 µM erlotinib cell line: BT20
GSM756865
GPL570
Part 1: BT20 6 hour time point rep3 BT20 cells, 6 hour post treatment with 10µM concentration of erlotinib time post treatment: 6 hours treatment: 10 µM erlotinib cell line: BT20
GSM756866
GPL570
Part 1: MD 0 minute time point rep1 MDA-MB-453 cells, 0 minutes post treatment with 10µM concentration of erlotinib time post treatment: 0 minutes treatment: 10 µM erlotinib cell line: MDA-MB-453
GSM756867
GPL570
Part 1: MD 0 minute time point rep2 MDA-MB-453 cells, 0 minutes post treatment with 10µM concentration of erlotinib time post treatment: 0 minutes treatment: 10 µM erlotinib cell line: MDA-MB-453
GSM756868
GPL570
Part 1: MD 0 minute time point rep3 MDA-MB-453 cells, 0 minutes post treatment with 10µM concentration of erlotinib time post treatment: 0 minutes treatment: 10 µM erlotinib cell line: MDA-MB-453
GSM756869
GPL570
Part 1: MD 1 day time point rep1 MDA-MB-453 cells, 24 hours post treatment with 10µM concentration of erlotinib time post treatment: 24 hours treatment: 10 µM erlotinib cell line: MDA-MB-453
GSM756870
GPL570
Part 1: MD 1 day time point rep2 MDA-MB-453 cells, 24 hours post treatment with 10µM concentration of erlotinib time post treatment: 24 hours treatment: 10 µM erlotinib cell line: MDA-MB-453
GSM756871
GPL570
Part 1: MD 1 day time point rep3 MDA-MB-453 cells, 24 hours post treatment with 10µM concentration of erlotinib time post treatment: 24 hours treatment: 10 µM erlotinib cell line: MDA-MB-453
GSM756872
GPL570
Part 2: MCF 0 minute time point rep1 MCF cells, 0 minutes post treatment with 10µM concentration of erlotinib time post treatment: 0 minutes treatment: 10 µM erlotinib cell line: MCF
GSM756873
GPL570
Part 2: MCF 0 minute time point rep2 MCF cells, 0 minutes post treatment with 10µM concentration of erlotinib time post treatment: 0 minutes treatment: 10 µM erlotinib cell line: MCF
GSM756874
GPL570
Part 2: MCF 0 minute time point rep3 MCF cells, 0 minutes post treatment with 10µM concentration of erlotinib time post treatment: 0 minutes treatment: 10 µM erlotinib cell line: MCF
GSM756875
GPL570
Part 2: MCF 1 day time point rep1 MCF cells, 24 hour post treatment with 10µM concentration of erlotinib time post treatment: 24 hours treatment: 10 µM erlotinib cell line: MCF
GSM756876
GPL570
Part 2: MCF 1 day time point rep2 MCF cells, 24 hour post treatment with 10µM concentration of erlotinib time post treatment: 24 hours treatment: 10 µM erlotinib cell line: MCF
GSM756877
GPL570
Part 2: MCF 1 day time point rep3 MCF cells, 24 hour post treatment with 10µM concentration of erlotinib time post treatment: 24 hours treatment: 10 µM erlotinib cell line: MCF
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes